Reducing Neonatal Morbidity by Discontinuing Oxytocin During the Active Phase of 1st Stage of Labor
Condition(s):Neonatal MorbidityLast Updated:September 6, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Neonatal MorbidityLast Updated:September 6, 2023Completed
Condition(s):PPROM; Respiratory Distress Syndrome in Premature InfantsLast Updated:January 26, 2024Terminated
Condition(s):Fetal MalnutritionLast Updated:March 15, 2018Unknown status
Condition(s):Covid19; Thymic HypoplasiaLast Updated:July 14, 2020Unknown status
Condition(s):Neonatal Respiratory Distress SyndromeLast Updated:December 27, 2019Completed
Condition(s):Preterm BirthLast Updated:April 11, 2016Completed
Condition(s):Preterm Infant; Morbidity;Infant; Outcome, FatalLast Updated:April 7, 2017Completed
Condition(s):Respiratory Distress Syndrome; Transient Tachypnea of Newborn; Intrauterine Growth RetardationLast Updated:November 27, 2019Completed
Condition(s):Sleep Apnea; ObesityLast Updated:November 14, 2023Completed
Condition(s):Neonatal Hypocalcemia; Neonatal SepsisLast Updated:May 29, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.